Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Neuroblastoma 5Wilms Tumor 1Oligodendroglioma 1Neuroendocrine Tumors 1Glioma 1Astrocytoma 1

Interventions

Filgrastim 9X-Rays 7Phantoms, Imaging 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Granulocyte Colony-Stimulating Factor 6Temozolomide 5Nuclear Medicine Department, Hospital 5Melphalan 5Cyclophosphamide 5Busulfan 5Stem Cell Transplantation 4Carboplatin 4Biopsy 4Topotecan 3Thiotepa 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Itraconazole 3Ifosfamide 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2sargramostim 2palbociclib 2olaparib 2liposomal amphotericin B 2larotrectinib 2ixabepilone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Tretinoin × CNS × Clear all
NCT00001509 2008-03-04

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled
CNSGenitourinary

Wilms Tumor, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡